Evaluation of the ROX index in SARS-CoV-2 acute respiratory failure treated with both high-flow nasal oxygen (HFNO) and continuous positive airway pressure …

…, M Prabhakar, A Navarra, R Mogal, A Barlow, N Nordin… - MedRxiv, 2021 - medrxiv.org
Background Non-invasive respiratory support including high-flow nasal oxygen (HFNO), and
continuous positive airway pressure (CPAP) have been used to provide therapy in selected …

Relevance of prediction scores derived from the SARS-CoV-2 first wave, in the evolving UK COVID-19 second wave, for safe early discharge and mortality: a …

…, B Critchlow, T Vaghela, M Schechter, N Nordin… - BMJ open, 2022 - bmjopen.bmj.com
Objective Prospectively validate prognostication scores, SOARS and 4C Mortality Score,
derived from the COVID-19 first wave, for mortality and safe early discharge in the evolving …

[HTML][HTML] The mental health of staff working on intensive care units over the COVID-19 winter surge of 2020 in England: a cross sectional survey

CE Hall, J Milward, C Spoiala, JK Bhogal… - British journal of …, 2022 - Elsevier
Background The COVID-19 pandemic generated a surge of critically ill patients greater than
the capacity of the UK National Health Service (NHS). There have been multiple well-…

Effect of noninvasive respiratory strategies on intubation or mortality among patients with acute hypoxemic respiratory failure and COVID-19: the RECOVERY-RS …

GD Perkins, C Ji, BA Connolly, K Couper, R Lall… - Jama, 2022 - jamanetwork.com
Importance Continuous positive airway pressure (CPAP) and high-flow nasal oxygen (HFNO)
have been recommended for acute hypoxemic respiratory failure in patients with COVID-19…

Effect of a low vs intermediate tidal volume strategy on ventilator-free days in intensive care unit patients without ARDS: a randomized clinical trial

FD Simonis, AS Neto, JM Binnekade, A Braber… - Jama, 2018 - jamanetwork.com
Importance It remains uncertain whether invasive ventilation should use low tidal volumes
in critically ill patients without acute respiratory distress syndrome (ARDS). Objective To …

Conditional power: how likely is trial success?

BR Saville, MA Detry, K Viele - JAMA, 2023 - jamanetwork.com
Because of the costsand potential risks to participants, clinical trials should be initiated or
continued only when there is a reasonable chance the results will improve clinical care or …

Extracorporeal Carbon Dioxide Removal vs Standard Care Ventilation Effect on 90-Day Mortality in Patients With Acute Hypoxemic Respiratory Failure

A Batchinsky, T Roberts, L Cancio - JAMA, 2022 - jamanetwork.com
To the Editor The REST trial, 1 which compared extracorporeal carbon dioxide removal (ECCO2R)
with lower tidal volume ventilation vs standard lung-protective ventilation for patients …

Association of angiotensin-converting enzyme inhibitor or angiotensin receptor blocker use with COVID-19 diagnosis and mortality

EL Fosbøl, JH Butt, L Østergaard, C Andersson… - Jama, 2020 - jamanetwork.com
Importance It has been hypothesized that angiotensin-converting enzyme inhibitors (ACEIs)/angiotensin
receptor blockers (ARBs) may make patients more susceptible to coronavirus …

Effect of discontinuing vs continuing angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on days alive and out of the hospital in patients …

RD Lopes, AVS Macedo, PGMBE Silva… - Jama, 2021 - jamanetwork.com
Importance It is unknown whether angiotensin-converting enzyme inhibitors (ACEIs) or
angiotensin II receptor blockers (ARBs) have a positive, neutral, or negative effect on clinical …

Renin-angiotensin system modulation with synthetic angiotensin (1-7) and angiotensin II type 1 receptor–biased ligand in adults with COVID-19: two randomized …

WH Self, MS Shotwell, KW Gibbs, M De Wit, DC Files… - Jama, 2023 - jamanetwork.com
Importance Preclinical models suggest dysregulation of the renin-angiotensin system (RAS)
caused by SARS-CoV-2 infection may increase the relative activity of angiotensin II …